JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


The Journal of Nuclear Medicine Vol. 29 No. 9 1582-1586
© 1988 by Society of Nuclear Medicine
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Krahwinkel, W.
Right arrow Articles by Feinendegen, L.E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Krahwinkel, W.
Right arrow Articles by Feinendegen, L.E.

Pharmacokinetics of Thallium-201 in Normal Individuals After Routine Myocardial Scintigraphy

W. Krahwinkel, H. Herzog and L.E. Feinendegen

Institute of Medicine, Nuclear Research Center Jüelich, Jüelich, FRG

Correspondence: For reprints contact: Hans Herzog, PhD, Institute of Medicine, Nuclear Research Center Jülich, P.O.B. 1913, D-5170 Jülich, Federal Republic of Germany.

ABSTRACT

Data of pharmacokinetic distribution of and radiation dose from 201Tl chloride used in routine myocardial scintigraphy are based on animal studies or on small groups of humans not exercised. In order to obtain data under routine conditions pharmacokinetics of 201Tl were measured in 15 individuals who had undergone diagnostic myocardial scintigraphy and were classified as normal. Ventral and dorsal whole-body scans were acquired until 9 days after injection. Conjugate pixels were averaged geometrically. Percentage values of total administered dose were obtained for total body and 13 organs by using a calculation method that takes into account the differentiation of overlapping organs.




This article has been cited by other articles:


Home page
JNMHome page
M. G. Stabin
Radiopharmaceuticals for Nuclear Cardiology: Radiation Dosimetry, Uncertainties, and Risk
J. Nucl. Med., September 1, 2008; 49(9): 1555 - 1563.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
S. R. Thomas, M. G. Stabin, and F. P. Castronovo
Radiation-Absorbed Dose from 201Tl-Thallous Chloride
J. Nucl. Med., March 1, 2005; 46(3): 502 - 508.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
O. Blagosklonov, A. Sabbah, J. Verdenet, M. Baud, and J.-C. Cardot
Poststress Motionlike Artifacts Caused by the Use of a Dual-Head Gamma Camera for 201Tl Myocardial SPECT
J. Nucl. Med., March 1, 2002; 43(3): 285 - 291.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
M. Nanasato, A. Ando, S. Isobe, M. Nonokawa, H. Hirayama, N. Tsuboi, T. Ito, M. Hirai, M. Yokota, and H. Saito
Evaluation of Left Ventricular Function Using Electrocardiographically Gated Myocardial SPECT with 123I-Labeled Fatty Acid Analog
J. Nucl. Med., December 1, 2001; 42(12): 1747 - 1756.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 1988 by the Society of Nuclear Medicine.